Global Digital PCR Market - By Product (Instruments and Reagents & Consumables), By End-User (Hospitals & Clinics, Academic & Research Organization, Diagnostic Centers, Pharmaceutical & Biotechnology Industries, and Other End-Users), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Oct 2023
- Report ID: 67760
- Number of Pages: 250
The Global Digital PCR Market size is expected to be worth around USD 1,803 Million by 2032 from USD 450 Million in 2022, growing at a CAGR of 15.3% during the forecast period from 2023 to 2032.
The biotechnological development of the conventional polymerase chain reaction is the digital polymerase chain reaction or dPCR. It is a sensitive and reproducible way to measure the amount of DNA or RNA in a sample using a high-throughput absolute quantitative method. Some of the most important factors anticipated to drive market growth over the forecast period are an increase in acquisitions, the introduction of new products, and the growing adoption of digital devices by laboratories for cancer, infectious diseases, and genetic disorders.
In addition, digital device technological advancements are anticipated to contribute to market expansion over the forecast period. During the forecast period, there will likely be less demand for COVID-19 infection diagnostic tests due to a significant decline in industry growth. However, some key factors exist, such as the rising demand for advanced diagnostics and the expanding use of PCR in research and forensic laboratories. In addition, it is anticipated that contract research organizations and the introduction of new technologies will propel PCR test demand forward during the forecast period.
- In 2022, instruments represented 34% of revenue generated across product categories.
- Technology-wise, digital droplet PCR holds the largest market share.
- By indication, genetic disorders have emerged as the leader of this market and experienced the highest compound annual compound annual compound growth from 2023 to 2032.
- By end-user segment, academic & research organizations held the greatest share of the market.
- North America held the highest revenue share with 42%.
- Europe will experience sustained compound annualized growth between 2023-2032.
The Instruments Segment Accounted for the Largest Market Share
The market has been segmented into instruments, and reagents & consumables are the market segments. In 2022, the instruments segment was accounted to have the largest market share. The significant market share is due to the increasing initiatives of prominent market players to launch new products and increase applications of these digital PCR equipment. During the forecast period, the reagents & consumables segment is expected to grow at the highest CAGR.
The increasing commercialization of these digital device kits for diagnostic purposes is responsible for the segment’s expansion. Additionally, governments granted emergency use authorization for specific digital COVID-19 diagnosis kits due to the COVID-19 pandemic, which is anticipated to boost market expansion in the long run.
The Droplet Digital PCR Segment held the Highest Market Share
Among the technology segment, the droplet digital PCR accounted for the largest market share. During the forecast period of 2023 to 2032, it is anticipated to expand at a substantial CAGR. Market participants are increasingly emphasizing the development and commercialization of dPCR for infectious disease diagnostics, which accounts for the expansion.
In addition, the advantages of these devices over other PCR in disease diagnosis and the rising incidence of infectious diseases are anticipated to boost segment growth over the forecast period. During the forecast period, the chip-based digital PCR market is anticipated to expand at a moderate CAGR. Chip-based digital PCR’s ability to detect strain specificity with less variation than the current standard of plate count enumeration and quantitative polymerase chain reaction (qPCR) is the reason for the segmental growth.
The Genetic Disorders Segment Dominated the Market
Genetic disorders, oncology, infectious diseases, and others are market segments. The market for genetic disorders is dominant and is anticipated to expand at a moderate CAGR between 2023 and 2032. Due to their specificity and high sensitivity in detection, these devices are increasingly being used to identify gene alterations, which accounts for the segment’s expansion. During the forecast period, the oncology segment is anticipated to expand at a substantial CAGR.
The growing use of digital devices such as these in cancer research and the rising prevalence of cancer diseases are two factors that have contributed to the segment’s expansion. During the forecast period, the infectious diseases sector is expected to expand at the highest CAGR. It is anticipated that the use of these digital droplet devices in diagnosing infectious diseases, including infections caused by bacteria, viruses, and parasites, will rise due to their clinically demonstrated potential advantages.
The Academic & Research Organizations Segment held the Largest Market Share
Hospitals & clinics, academic & research organizations, diagnostic centers, pharmaceutical & biotechnology industries, and others comprise the market. During the forecast period, the academic & research organizations segment is anticipated to expand at a moderate CAGR and hold the dominant share. The increasing use of these devices in research studies in various fields, including genetic diseases, oncology, and others, is responsible for expanding this market segment.
During the forecast period, the diagnostics centers segment is anticipated to expand at the highest CAGR. The growth of this market segment can be attributed to the increasing use of digital diagnostic tools for infectious diseases and their rising prevalence. Additionally, due to the COVID-19 outbreak, numerous market participants increased their focus on creating and selling COVID-19 diagnostic kits.
Key Market Segments
Based on Product
- Reagents & Consumables
Based on Technology
- Droplet Digital PCR (ddPCR)
- Chip-Based Digital PCR
- Other Technologies
Based on Indication
- Genetic Disorders
- Infectious Diseases
- Other Applications
Based on End-User
- Hospitals & Clinics
- Academic & Research Organization
- Diagnostic Centers
- Pharmaceutical & Biotechnology Industries
- Other End-Users
Increasing Frequency of Infectious Diseases
As demonstrated, various infectious agents have been detected in trace amounts using PCR. The organisms of interest vary in terms of the optimal amplification conditions. Three assay systems were developed for Mycobacterium tuberculosis, for amplifying human T cell leukemia virus type I, and for Mycoplasma pneumonia.
PCR was used as a rapid and sensitive method for detecting infectious agents. All of these factors will drive the market. In addition, the increasing incidence of infectious diseases and the advancing age of the population significantly impact the expansion of the market for real-time PCR technology.
Increasing R&D Activities
Market expansion is anticipated to be fuelled by the rising use of PCR for cancer diagnosis. In addition, because of the high demand for personalized medicines and genetic engineering, the market is expected to expand strongly over the forecast period. All of these factors are to blame for the rise in demand for this method and research and development activities to provide cutting-edge forensic science and molecular biology.
Costly Technology Hindered the Market’s Growth
Technical limitations and the high cost of technology will impede the market’s growth rate. During the forecast period, the digital PCR market may be hindered by high d-PCR device costs and technical limitations of q-PCR and d-PCR techniques. In contrast, the most significant obstacle to expanding the digital polymerase chain reaction (PCR) market is the widespread application and adoption of MIQE guidelines.
Increasing Demand for PCR
The rising demand for personalized medicines accounts for most of the market opportunities. It will be highly beneficial to have technology that can gather information at the molecular level for disease detection. All screening techniques make extensive use of polymerized chain reaction techniques. The biotechnology sector benefited from the introduction of the polymerase chain reaction.
The major pharmaceutical industry and the life sciences rely heavily on the polymerase chain reaction. The demand for PCR technology is estimated to rise significantly in the coming years as the devices are used extensively for drug discovery.
North America Dominates the Global Digital PCR Market During the Forecast Period
With a revenue share of 42%, the North America market is anticipated to expand at a substantial CAGR over the forecast period. The population’s high alertness and economic stability are the reasons for the expansion. In addition, the regional market is anticipated to expand during the forecast period due to the growing use of high-tech, expensive diagnostics in the region.
During the forecast period, Europe is anticipated to expand at a moderate CAGR. Substantial volumes of infectious diagnostics in key European nations and rising European expenditures on R&D account for the expansion. During the forecast period, the market in the Asia-Pacific region is anticipated to expand at the highest CAGR. Improving healthcare infrastructure in Asian nations, rising public awareness of improved treatment outcomes, and the region’s high prevalence of chronic and infectious diseases are all contributing factors to the region’s expanding market.
- North America
- The US
- Western Europe
- The UK
- Rest of Western Europe
- Eastern Europe
- The Czech Republic
- Rest of Eastern Europe
- South Korea
- Australia & New Zealand
- Rest of APAC
- Latin America
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- United Arab Emirates
- Rest of MEA
Key Players Analysis
Strong Focus on Acquisitions and Partnerships to Strengthen Leading Players’ Market Position and a Diverse Portfolio
Due to significant market shares held by key market players, the market is consolidated. Bio-Rad Laboratories, Inc. ruled the market with the largest share of the digital PCR market. The company’s robust product portfolio, which includes a wide range of instruments and consumables, positively impacts the market.
Additionally, the company’s substantial market share is the result of previous acquisitions of other manufacturers of digital devices. A few major players in the market are Fluidigm Corporation, Promega Corporation, Danaher Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., ELITech Group, Analytik Jena AG, Roche Sequencing, BioMérieux SA, and other key companies.
Listed below are some of the most prominent global digital PCR market players.
Market Key Players
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- JN Medsys
- Sysmex Corporation
- Standard BioTools
- Precigenome LLC.
- Other Key Players
Key Industry Developments
- In September 2021 – A digital PCR system from Thermo Fisher Scientific was introduced. It is designed to deliver highly accurate and consistent results within 90 minutes.
- In July 2021 – Stilla Technologies’ sic Color Crystal Digital PCR (dPCR) access program was launched. It gives the business community early access to its digital polymerase chain reaction (PCR) system with six fluorescent channels.
Report Features Description Market Value (2022) USD 450 Mn Forecast Revenue (2032) USD 1,803 Mn CAGR (2023-2032) 15.3% Base Year for Estimation 2022 Historic Period 2016-2022 Forecast Period 2023-2032 Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments Segments Covered By Product- Instruments and Reagents & Consumables; By Technology– Droplet Digital PCR (ddPCR), Chip-Based Digital PCR, and Other Technologies; By Indication- Genetic Disorders, Oncology, Infectious Diseases, and Other Applications; and By End-User- Hospitals & Clinics, Academic & Research Organization, Diagnostic Centers, Pharmaceutical & Biotechnology Industries, and Other End-Users. Regional Analysis North America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; The Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA. Competitive Landscape QIAGEN, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., JN Medsys, Stilla, Sysmex Corporation, Standard BioTools, Precigenome LLC., and Other Key Players. Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)
Frequently Asked Questions (FAQ)What is the Digital PCR Market research report, and what does it cover?
The Digital PCR Market research report is a comprehensive study that provides insights into the global market for digital PCR (Polymerase Chain Reaction). It covers market trends, key players, growth drivers, and challenges, as well as market segmentation based on product type, application, and geography.Who can benefit from reading the Digital PCR Market research report?
The Digital PCR Market research report is a valuable resource for researchers, clinicians, medical device manufacturers, investors, and anyone interested in understanding the digital PCR market. It can help stakeholders make informed decisions regarding investments, product development, and market expansion.What are the key drivers of growth in the Digital PCR Market?
The key drivers of growth in the Digital PCR Market include the increasing demand for precise and reliable results in research and clinical applications, growing adoption of digital PCR in genetic testing and personalized medicine, and technological advancements in digital PCR systems. Additionally, the rising prevalence of infectious diseases and genetic disorders worldwide also contributes to market growth.What are the challenges facing the Digital PCR Market?
The Digital PCR Market faces several challenges, including the high cost of digital PCR instruments and reagents, limited awareness and accessibility of digital PCR technology, and lack of standardization and validation of digital PCR assays.
| Single User
USD / per unit
| Multi User
USD / per unit
| Corporate User
USD / per unit
|Report Library Access
|Data Set (Excel)
|Company Profile Library Access
|up to 10 hrs work
|up to 30 hrs work
|up to 20 hrs
|up to 40 hrs
|up to 50 hrs
|Up to 20% off on next purchase
|Up to 25% off on next purchase
|Up to 30% off on next purchase
|Buy Now ($ 3,499)
|Buy Now ($ 4,299)
|Buy Now ($ 4,999)